Market Cap ₹38 Cr.
Stock P/E
P/B 1.9
Current Price ₹25.4
Book Value ₹ 13.3
Face Value 10
52W High ₹31.1
Dividend Yield 0%
52W Low ₹ 15
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|
Net Sales | 15 | 15 | 23 | 19 | 21 | |
Other Income | 0 | 1 | 0 | 0 | 3 | |
Total Income | 15 | 17 | 23 | 20 | 24 | |
Total Expenditure | 14 | 14 | 19 | 16 | 19 | |
Operating Profit | 1 | 3 | 4 | 4 | 5 | |
Interest | 2 | 2 | 2 | 2 | 1 | |
Depreciation | 1 | 1 | 1 | 3 | 3 | |
Exceptional Income / Expenses | -0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | -1 | -0 | 1 | -0 | 1 | |
Provision for Tax | -0 | 0 | -0 | -0 | 0 | |
Profit After Tax | -1 | -0 | 1 | -0 | 1 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | -1 | -0 | 1 | -0 | 1 | |
Adjusted Earnings Per Share | -2 | -0.7 | 2.5 | -0.2 | 0.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 11% | 12% | 0% | 0% |
Operating Profit CAGR | 25% | 19% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 5% | NA% | NA% | NA% |
ROE Average | 9% | -1% | -1% | -1% |
ROCE Average | 10% | 13% | 11% | 11% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Shareholder's Funds | 17 | 17 | 18 | 38 | 52 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 |
Borrowings | 2 | 2 | 13 | 4 | 7 |
Other Non-Current Liabilities | -0 | -0 | 1 | 2 | 3 |
Total Current Liabilities | 18 | 22 | 8 | 8 | 3 |
Total Liabilities | 38 | 41 | 41 | 52 | 65 |
Fixed Assets | 34 | 37 | 37 | 48 | 50 |
Other Non-Current Assets | 1 | 1 | 1 | 0 | 5 |
Total Current Assets | 2 | 3 | 3 | 4 | 9 |
Total Assets | 38 | 41 | 41 | 52 | 65 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 5 | 6 | 4 | 4 | -3 |
Cash Flow from Investing Activities | -5 | -5 | -1 | -3 | -8 |
Cash Flow from Financing Activities | -1 | -1 | -4 | -1 | 11 |
Net Cash Inflow / Outflow | -0 | 0 | -0 | 0 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | -2.02 | -0.72 | 2.5 | -0.2 | 0.75 |
CEPS(Rs) | -0.78 | 1.07 | 4.27 | 2.32 | 2.46 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | -7.54 | -8.26 | -5.76 | 6.23 | 13.27 |
Core EBITDA Margin(%) | 6.36 | 8.7 | 18.25 | 17.42 | 8.51 |
EBIT Margin(%) | 3.54 | 10.76 | 14.6 | 6.74 | 10.95 |
Pre Tax Margin(%) | -7.65 | -2.06 | 5.41 | -1.53 | 6.14 |
PAT Margin (%) | -7.11 | -2.37 | 5.53 | -1.05 | 5.35 |
Cash Profit Margin (%) | -2.74 | 3.53 | 9.45 | 11.9 | 17.52 |
ROA(%) | -2.75 | -0.93 | 3.12 | -0.44 | 1.92 |
ROE(%) | 0 | 0 | 0 | -12.4 | 8.61 |
ROCE(%) | 4.16 | 11.45 | 20.89 | 8.39 | 10.39 |
Receivable days | 3.38 | 1.91 | 1.24 | 6.52 | 9.98 |
Inventory Days | 40.67 | 38.9 | 29.02 | 35.81 | 36.62 |
Payable days | 755.81 | 810.31 | 249.88 | 1188.88 | -2108.48 |
PER(x) | 0 | 0 | 0 | 0 | 18.26 |
Price/Book(x) | 0 | 0 | 0 | 0 | 1.03 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.46 | 1.67 | 1.02 | 0.99 | 1.19 |
EV/Core EBITDA(x) | 17.61 | 10.02 | 5.49 | 5.02 | 5.15 |
Net Sales Growth(%) | 0 | 6.59 | 48.9 | -15.52 | 7.97 |
EBIT Growth(%) | 0 | 224.08 | 101.95 | -60.98 | 75.29 |
PAT Growth(%) | 0 | 64.45 | 447.05 | -115.98 | 651.84 |
EPS Growth(%) | 0 | 64.45 | 447.05 | -108.17 | 467.7 |
Debt/Equity(x) | -4.21 | -4.97 | -6.26 | 1.54 | 0.43 |
Current Ratio(x) | 0.12 | 0.15 | 0.34 | 0.44 | 2.85 |
Quick Ratio(x) | 0.03 | 0.07 | 0.1 | 0.22 | 2.11 |
Interest Cover(x) | 0.32 | 0.84 | 1.59 | 0.81 | 2.28 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.42 |
# | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|
Promoter | 64.03 | 64.03 | 64.67 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 35.97 | 35.97 | 35.33 |
Others | 0 | 0 | 0 |
Total | 100 | 100 | 100 |
# | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|
Promoter | 0.96 | 0.96 | 0.97 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 0.54 | 0.54 | 0.53 |
Others | 0 | 0 | 0 |
Total | 1.5 | 1.5 | 1.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About